J. Hakim

T. Flanigan, V. De Gruttola, L. Smeaton, 2010, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Understanding Ethical, Legal and Societal Issues (ELSIs) in Human Biobanking and Genomics for Research and Healthcare in Zimbabwe: The Genomics Inheritance Law Ethics and Society (GILES) initiative

M. Cho, A. Matimba, J. Hakim, 2019, AAS open research.

Understanding Ethical, Legal and Societal Issues (ELSIs) in Human Biobanking and Genomics for Research and Healthcare in Zimbabwe: The Genomics Inheritance Law Ethics and Society GILES initiative.

M. Cho, A. Matimba, J. Hakim, 2019, AAS open research.

Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe.

R. Heyderman, J. Hakim, P. Mason, 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Myocardial dysfunction in human immunodeficiency virus infection: an echocardiographic study of 157 patients in hospital in Zimbabwe.

S. Siziya, J. Hakim, J. Matenga, 1996, Heart.

Hepatitis C virus and HIV antibodies in patients with hepatocellular carcinoma in Zimbabwe: a pilot study.

J. Hakim, I. Gudza, O. Tobaiwa, 1997, Transactions of the Royal Society of Tropical Medicine and Hygiene.

Tobacco use among people living with HIV: analysis of data from Demographic and Health Surveys from 28 low-income and middle-income countries

K. Siddiqi, O. Ayo-Yusuf, J. Hakim, 2017, The Lancet. Global health.

Lopinavir plus nucleoside reverse-transcriptase inhibitors, lopinavir plus raltegravir, or lopinavir monotherapy for second-line treatment of HIV (EARNEST): 144-week follow-up results from a randomised controlled trial

P. Easterbrook, H. Namata, A. Siika, 2018, The Lancet. Infectious diseases.

Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy

M. Hughes, T. Flanigan, L. Smeaton, 2016, HIV clinical trials.

Rationale and design of the Investigation of the Management of Pericarditis (IMPI) trial: a 2 × 2 factorial randomized double-blind multicenter trial of adjunctive prednisolone and Mycobacterium w immunotherapy in tuberculous pericarditis.

S. Yusuf, J. Bosch, J. Pogue, 2013, American heart journal.

Clinical trials in the use of antiretroviral therapy in developing countries: results and challenges

J. Hakim, Nehemiah Nhando, Anthony Chisada, 2007 .

Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial

A. Walker, A. Siika, R. Heyderman, 2018, PLoS medicine.

Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients

S. Siziya, J. Hakim, V. Robertson, 2000, Heart.

Impact of HIV infection on meningitis in Harare, Zimbabwe: a prospective study of 406 predominantly adult patients

R. Heyderman, J. Hakim, P. Mason, 2000, AIDS.

Phylogenetic methods inconsistently predict direction of HIV transmission among heterosexual pairs in the HPTN052 cohort.

C. Fraser, O. Laeyendecker, T. Quinn, 2019, The Journal of infectious diseases.

Characterization of HIV–HBV coinfection in a multinational HIV-infected cohort

S. Kulkarni, C. Thio, U. Lalloo, 2013, AIDS.

Endomyocardial fibrosis in Zimbabwe--how rare is it? A report of two cases.

J. Hakim, J. Matenga, I. Ternouth, 1996, The Central African journal of medicine.

Pre-cART Elevation of CRP and CD4+ T-Cell Immune Activation Associated With HIV Clinical Progression in a Multinational Case–Cohort Study

R. Bollinger, U. Lalloo, D. Asmuth, 2015, Journal of acquired immune deficiency syndromes.

A Randomized Comparison of Anthropomorphic Changes With Preferred and Alternative Efavirenz-Based Antiretroviral Regimens in Diverse Multinational Settings

M. Hughes, K. Erlandson, L. Smeaton, 2015, Open forum infectious diseases.

Antiretroviral Therapy for the Prevention of HIV-1 Transmission.

J. Gallant, S. Swindells, I. Hoffman, 2016, The New England journal of medicine.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Nucleoside reverse-transcriptase inhibitor cross-resistance and outcomes from second-line antiretroviral therapy in the public health approach: an observational analysis within the randomised, open-label, EARNEST trial

P. Easterbrook, T. Peto, N. French, 2017, The lancet. HIV.

Peripartum cardiomyopathy among cardiovascular patients referred for echocardiography at Parirenyatwa Teaching Hospital, Harare, Zimbabwe

J. Hakim, D. Kao, J. Matenga, 2017, Cardiovascular journal of Africa.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

R. Bollinger, D. Asmuth, K. Erlandson, 2016, The Journal of infectious diseases.

In ﬂ ammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults

R. Bollinger, D. Asmuth, D. Thomas, 2016 .

Enhanced infection prophylaxis reduces mortality in severely immunosuppressed HIV-infected adults and older children initiating antiretroviral therapy in Kenya, Malawi, Uganda and Zimbabwe: the REALITY trial

K. Maitland, A. Siika, C. Kityo, 2016 .

CRP and CD 4 + t-cell immune activation associated with HIV clinical progression in a multinational case-cohort study

R. Bollinger, U. Lalloo, D. Asmuth, 2015 .

Rheumatic fever and rheumatic heart disease among children presenting to two referral hospitals in Harare, Zimbabwe.

J. Hakim, D. Kao, J. Matenga, 2015, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

New Insights on Long-Term Hepatitis B Virus Responses in HIV-Hepatitis B virus Co-infected Patients: Implications for Antiretroviral Management in Hepatitis B virus-Endemic Settings.

P. Kaleebu, D. Pillay, C. Gilks, 2021, Journal of acquired immune deficiency syndromes.

“Well, not me, but other women do not register because...”- Barriers to seeking antenatal care in the context of prevention of mother-to-child transmission of HIV among Zimbabwean women: a mixed-methods study

I. Weller, J. Hakim, F. Cowan, 2018, BMC Pregnancy and Childbirth.

Prevention of HIV-1 infection with early antiretroviral therapy.

Lei Wang, David Burns, Kenneth H Mayer, 2011, The New England journal of medicine.

Evaluation of Phylogenetic Methods for Inferring the Direction of Human Immunodeficiency Virus (HIV) Transmission: HIV Prevention Trials Network (HPTN) 052

C. Fraser, O. Laeyendecker, C. Wymant, 2020, Clinical Infectious Diseases.

Evaluation of phylogenetic methods for inferring the direction of HIV transmission: HPTN 052.

C. Fraser, O. Laeyendecker, C. Wymant, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virologic outcomes in early antiretroviral treatment: HPTN 052

J. Gallant, Myron S. Cohen, K. Mayer, 2017, HIV clinical trials.

Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy.

M. Hughes, T. Flanigan, T. Campbell, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Insulin-Like Growth Factor Is Associated with Changes in Body Composition with Antiretroviral Therapy Initiation.

U. Lalloo, T. Brown, K. Erlandson, 2017, AIDS research and human retroviruses.

Insulin-like Growth Factor is Associated with Changes in Body Composition with ART Initiation

U. Lalloo, T. Brown, K. Erlandson, 2017 .

D. Asmuth, J. Currier, S. Cohn, 2016, Journal of acquired immune deficiency syndromes.

Clinical Differences between Younger and Older Adults with HIV/AIDS Starting Antiretroviral Therapy in Uganda and Zimbabwe: A Secondary Analysis of the DART Trial

Sujal M. Parikh, A. Semeere, C. Kityo, 2013, PloS one.

Clinically relevant enantiomer specific R‐ and S‐praziquantel pharmacokinetic drug‐drug interactions with efavirenz and ritonavir

C. Masimirembwa, J. Stingl, J. Hakim, 2021, Pharmacology research & perspectives.

Efficacy and Safety of Three Antiretroviral Regimens for Initial Treatment of HIV-1: A Randomized Clinical Trial in Diverse Multinational Settings

M. Wulfsohn, S. Hammer, R. Schooley, 2012, PLoS medicine.

Prevalence, Incidence and Predictors of Severe Anaemia with Zidovudine-Containing Regimens in African Adults with HIV Infection within the Dart Trial

A. Walker, C. Gilks, J. Darbyshire, 2005, Antiviral therapy.

What can be done about effusive tuberculous pericarditis in HIV-seropositive patients?

J. Hakim, Adam S. Malilt, 2007 .

Analysis of genetic linkage of HIV from couples enrolled in the HIV Prevention Trials Network 052 trial.

Lei Wang, James P Hughes, Kenneth H Mayer, 2011, The Journal of infectious diseases.

Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results From the HIV Prevention Trials Network 052 Trial

J. Gallant, Myron S. Cohen, K. Mayer, 2016, Journal of acquired immune deficiency syndromes.

The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data

P. Kaleebu, D. Pillay, C. Gilks, 2017, BMC Infectious Diseases.

C-Reactive Protein (CRP), Interferon Gamma-Inducible Protein 10 (IP-10), and Lipopolysaccharide (LPS) Are Associated with Risk of Tuberculosis after Initiation of Antiretroviral Therapy in Resource-Limited Settings

R. Bollinger, D. Dowdy, D. Asmuth, 2015, PloS one.

ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing

J. Seeley, C. Giaquinto, O. Kobusingye, 2021, BMC Infectious Diseases.

Mortality in the Year Following Antiretroviral Therapy Initiation in HIV-Infected Adults and Children in Uganda and Zimbabwe

C. Gilks, E. Katabira, A. Walker, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Cardiac disease distribution among patients referred for echocardiography in Harare, Zimbabwe.

J. Hakim, J. Manyemba, 1998, The Central African journal of medicine.

One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

R. Chaisson, S. Swindells, C. Fletcher, 2019, The New England journal of medicine.

Does Trimethoprim-Sulfamethoxazole Prophylaxis for HIV Induce Bacterial Resistance to Other Antibiotic Classes?: Results of a Systematic Review

I. Weller, J. Hakim, F. Cowan, 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis.

John L. Johnson, K. Dooley, R. Chaisson, 2021, The New England journal of medicine.

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Epidemic in Zimbabwe: Quo Vadis?

J. Hakim, Lenon Gwaunza, L. Katsidzira, 2020, Clinical Infectious Diseases.

Eff ects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection : results from the phase 3 HPTN 052 randomised controlled trial

D. Havlir, J. Gallant, S. Swindells, 2014 .

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015

L. Lynen, S. Rusakaniko, J. Hakim, 2019, bioRxiv.

Antiretroviral therapies in women after single-dose nevirapine exposure.

M. Hughes, R. Schooley, J. Mellors, 2010, The New England journal of medicine.

Comparison of HBV-active HAART regimens in an HIV–HBV multinational cohort: outcomes through 144 weeks

S. Kulkarni, C. Thio, U. Lalloo, 2015, AIDS.

Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan Africa.

Philimon N. Gona, J. Hakim, A. Makadzange, 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The impact of first year adherence to antiretroviral therapy on long‐term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe

H. Oja, S. Kiwuwa-Muyingo, E. Katabira, 2012, Tropical medicine & international health : TM & IH.

Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa

K. Maitland, A. Siika, D. Gibb, 2017, The New England journal of medicine.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

J. Seeley, A. Walker, N. Klein, 2018 .

Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditis.

S. Yusuf, J. Bosch, J. Pogue, 2014, The New England journal of medicine.

Topical gentian violet compared with nystatin oral suspension for the treatment of oropharyngeal candidiasis in HIV-1-infected participants

K. Freedberg, M. Ghannoum, C. Shiboski, 2017, AIDS.

Benefits of enhanced infection prophylaxis at antiretroviral therapy initiation by cryptococcal antigen status.

L. Haddow, R. Heyderman, L. Benjamin, 2020, AIDS.

Chronic cough in primary health care attendees, Harare, Zimbabwe: diagnosis and impact of HIV infection.

S. Munyati, S. Rusakaniko, E. Corbett, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Nevirapine pharmacokinetics in HIV-infected persons receiving rifapentine and isoniazid for TB prevention.

R. Chaisson, S. Swindells, C. Fletcher, 2020, The Journal of antimicrobial chemotherapy.

Supporting Survivors of Stroke in Low Resource Settings

J. Hakim, L. Gwanzura, Tecla Mlambo, 2019, New Insight into Cerebrovascular Diseases - An Updated Comprehensive Review.

Pregnancy and Infant Outcomes among HIV-Infected Women Taking Long-Term ART with and without Tenofovir in the DART Trial

A. Walker, C. Gilks, D. Gibb, 2012, PLoS medicine.

Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.

Lerato Mohapi, Ian Sanne, Peter Mugyenyi, 2011, The New England journal of medicine.

Lablite: baseline mapping survey of decentralised ART service provision in Malawi, Uganda and Zimbabwe.

J. Seeley, P. Revill, H. Namata, 2012 .

Second assessment of NeuroAIDS in Africa

J. Clements, D. Clifford, N. Nakasujja, 2008, Journal of NeuroVirology.

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Ana C. Matos, C. Königs, C. Giaquinto, 2022, The lancet. HIV.

Differential human immunodeficiency virus risk factors among female general nurses, nurse midwives and office workers/teachers in Zambia.

S. Siziya, J. Hakim, 1996, The Central African journal of medicine.

HIV prevention in southern Africa: why we must reassess our strategies?

J. Hakim, L. Katsidzira, 2011, Tropical medicine & international health : TM & IH.

Supporting Information S1

Charles F. Gilks, Heiner Grosskurth, Peter Mugyenyi, 2010 .

Manuscript title: Facilitators and barriers to cotrimoxazole prophylaxis among HIV exposed babies: a qualitative study from Harare, Zimbabwe

I. Weller, J. Hakim, F. Cowan, 2015, BMC Public Health.

Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals: the International AIDS Society—Lancet Commission

M. Dybul, S. Lewin, D. Havlir, 2018, The Lancet.

Hematological and biochemical laboratory reference intervals for Zimbabwean adolescents.

W. Tinago, M. Munjoma, H. Mujuru, 2015, Clinical laboratory.

Adult Hematology and Clinical Chemistry Laboratory Reference Ranges in a Zimbabwean Population

W. Tinago, M. Munjoma, N. Mgodi, 2016, PloS one.

Assessment of neurocognitive deficits in people living with HIV in Sub Saharan Africa: A systematic review

H. Gouse, R. Robbins, J. Hakim, 2019, The Clinical neuropsychologist.

Association of HIV diversity and virologic outcomes in early antiretroviral treatment: HPTN 052

M. Hosseinipour, S. Chariyalertsak, B. Grinsztejn, 2017, PloS one.

The INVICTUS rheumatic heart disease research program: Rationale, design and baseline characteristics of a randomized trial of rivaroxaban compared to vitamin K antagonists in rheumatic valvular disease and atrial fibrillation.

S. Yusuf, A. Dans, Á. Avezum, 2020, American heart journal.

The Lablite project: A cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe

J. Seeley, P. Revill, H. Namata, 2014, BMC Health Services Research.

The magnitude of loss to follow-up of HIV-exposed infants along the prevention of mother-to-child HIV transmission continuum of care: a systematic review and meta-analysis

Frances M. Cowan, I. Weller, J. Hakim, 2013, AIDS.

Most HIV-infected individuals on antiretroviral therapy ( ART ) in low and middle-income countries are treated following the World Health

J. Seeley, P. Revill, H. Namata, 2014 .

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, Lancet.

Task-sharing with lay counsellors to deliver a stepped care intervention to improve depression, antiretroviral therapy adherence and viral suppression in people living with HIV: a study protocol for the TENDAI randomised controlled trial

R. Jopling, S. Safren, J. Hakim, 2022, BMJ Open.

High Rate of HIV Resuppression After Viral Failure on First-line Antiretroviral Therapy in the Absence of Switch to Second-line Therapy

A. Breckenridge, P. Kaleebu, D. Pillay, 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Ana C. Matos, C. Königs, J. Seeley, 2022, The lancet. HIV.

Annular subvalvular left ventricular aneurysm: A case report

J. Hakim, I. Gangaidzo, D. Chimuka, 1997 .

Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial

J. Seeley, A. Shali, A. Walker, 2018, The lancet. HIV.

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

P. Easterbrook, A. Siika, A. Kambugu, 2014, The New England journal of medicine.

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

M. Reitsma, J. Mellors, R. Kantor, 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

The Impact of Different CD4 Cell-Count Monitoring and Switching Strategies on Mortality in HIV-Infected African Adults on Antiretroviral Therapy: An Application of Dynamic Marginal Structural Models

J. Robins, M. Petersen, A. Walker, 2015, American journal of epidemiology.

A Single CD4 Test with 250 Cells/Mm3 Threshold Predicts Viral Suppression in HIV-Infected Adults Failing First-Line Therapy by Clinical Criteria

C. Gilks, E. Katabira, A. Walker, 2013, PloS one.

Evolution of Drug Resistance During 48 Weeks of Zidovudine/Lamivudine/Tenofovir in the Absence of Real-Time Viral Load Monitoring

P. Kaleebu, D. Pillay, C. Gilks, 2010, Journal of acquired immune deficiency syndromes.

District-level strategies to control the HIV epidemic in Zimbabwe: a practical example of precision public health

L. Lynen, S. Rusakaniko, J. Hakim, 2020, BMC Research Notes.

District-level differentiated HIV testing strategies are needed to achieve the 1st 90 in Zimbabwe

L. Lynen, S. Rusakaniko, J. Hakim, 2020 .

Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV “Treat All” in Zimbabwe

L. Lynen, T. Apollo, S. Rusakaniko, 2020, PloS one.

Patient-level benefits associated with decentralization of antiretroviral therapy services to primary health facilities in Malawi and Uganda.

J. Seeley, P. Revill, C. Gilks, 2018, International health.

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Kenneth H Mayer, Ian Sanne, Max Essex, 2014, The Lancet. Infectious diseases.

Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.

A. Siika, B. Castelnuovo, A. Kiragga, 2021, The New England journal of medicine.

Undisclosed antiretroviral drug use in a multinational clinical trial (HIV Prevention Trials Network 052).

K. Mayer, C. Hendrix, I. Sanne, 2013, The Journal of infectious diseases.

Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

J. Seeley, K. Maitland, A. Shali, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Simplified dolutegravir dosing for children with HIV weighing 20 kg or more: pharmacokinetic and safety substudies of the multicentre, randomised ODYSSEY trial

C. Giaquinto, H. Mujuru, D. Gibb, 2020, The lancet. HIV.

Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial.

P. Kaleebu, D. Pillay, C. Gilks, 2007 .

Impact of decentralisation of antiretroviral therapy services on HIV testing and care at a population level in Agago District in rural Northern Uganda: results from the Lablite population surveys.

J. Seeley, A. Phillips, P. Revill, 2017, International health.

Acute myocardial infarction in Zimbabwe: the changing scene of coronary artery disease.

S. Siziya, J. Hakim, J. Matenga, 1995, The Central African journal of medicine.

Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy.

I. Williams, C. Gilks, D. Gibb, 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Estimating Glomerular Filtration Rate in HIV-Infected Adults in Africa: Comparison of Cockcroft–Gault and Modification of Diet in Renal Disease Formulae

C. Gilks, J. Darbyshire, W. Stöhr, 2008, Antiviral therapy.

Opsoclonus-myoclonus associated with traditional medicine ingestion: case report.

B. Adamolekun, J. Hakim, 1998, East African medical journal.

Comparative skin testing with PPD tuberculin, Mycobacterium avium and M. scrofulaceum sensitin in schoolchildren in Saudi Arabia.

J. Hakim, M. Bentzon, M. Magnusson, 1994, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort

C. Gilks, J. Darbyshire, E. Katabira, 2010, The Lancet.

Implementation of antiretroviral therapy for life in pregnant/breastfeeding HIV+ women (Option B+) alongside rollout and changing guidelines for ART initiation in rural Zimbabwe: the Lablite Project experience

J. Seeley, C. Gilks, E. Katabira, 2017, Journal of acquired immune deficiency syndromes.

Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.

J. Baeten, U. Lalloo, T. Campbell, 2017, The Journal of infectious diseases.

Herpes Simplex Virus Type 2 Acquisition Among HIV-1–Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study

J. Baeten, U. Lalloo, T. Campbell, 2017, The Journal of infectious diseases.

Neurocognitive impairment in treatment-experienced adults living with HIV attending primary care clinics in Zimbabwe

H. Gouse, R. Robbins, J. Hakim, 2020, BMC Infectious Diseases.

Improved neuropsychological and neurological functioning across three antiretroviral regimens in diverse resource-limited settings: AIDS Clinical Trials Group study a5199, the International Neurological Study.

C. Marra, C. Marra, R. Price, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

NeuroAIDS in Africa

C. Adebamowo, I. Grant, R. Paul, 2010, Journal of NeuroVirology.

Metabolic syndrome disorders in urban black Zimbabweans with type 2 Diabetes mellitus.

M. Pleasant, J. Hakim, T. Munyombwe, 2004, The Central African journal of medicine.

Clinical characteristics and outcomes of patients with stroke admitted to three tertiary hospitals in Zimbabwe: A retrospective one-year study

J. Hakim, L. Gwanzura, A. Stewart, 2017, Malawi medical journal : the journal of Medical Association of Malawi.

Clinical characteristics and outcomes of patients with stroke admitted in tertiary hospitals in Zimbabwe : A retrospective one-year study

J. Hakim, L. Gwanzura, A. Stewart, 2017 .

Nursing and community rates of Mycobacterium tuberculosis infection among students in Harare, Zimbabwe.

Y. Cheung, S. Munyati, E. Corbett, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Distal Sensory Peripheral Neuropathy in Human Immunodeficiency Virus Type 1-Positive Individuals Before and After Antiretroviral Therapy Initiation in Diverse Resource-Limited Settings.

C. Marra, C. Hall, N. Sacktor, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV Drug Resistance in Adults Receiving Early vs. Delayed Antiretroviral Therapy: HPTN 052

J. Gallant, J. Eron, M. Hosseinipour, 2017, Journal of acquired immune deficiency syndromes.

Review NeuroAIDS in Afr ica

J. Hakim, Kevin Robertson, 2010 .

Evolution of Protease Inhibitor Resistance in Human Immunodeficiency Virus Type 1 Infected Patients Failing Protease Inhibitor Monotherapy as Second-line Therapy in Low-income Countries: An Observational Analysis Within the EARNEST Randomized Trial

P. Easterbrook, N. French, H. Namata, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Virological findings from the SARA trial: boosted PI monotherapy as maintenance second-line ART in Africa

P. Kaleebu, D. Pillay, D. Gibb, 2010, Journal of the International AIDS Society.

Renal and Metabolic Toxicities Following Initiation of HIV-1 Treatment Regimen in a Diverse, Multinational Setting: A Focused Safety Analysis of ACTG PEARLS (A5175)

T. Flanigan, L. Smeaton, T. Campbell, 2014, HIV clinical trials.

Prevalence and risk of residual viremia after ART in low- and middle-income countries

J. Lifson, K. Ruxrungtham, S. Kerr, 2021, Medicine.

Feasibility and sustainability of an interactive team-based learning method for medical education during a severe faculty shortage in Zimbabwe

Thomas B Campbell, M. Borok, E. Aagaard, 2014, BMC medical education.

Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial

M. Mimiaga, U. Lalloo, D. Celentano, 2014, PloS one.

HIV Associated Neurocognitive Impairment in Diverse Resource Limited Settings.

C. Marra, C. Hall, N. Sacktor, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

HIV-1 and TB Co-infection in Multinational Resource Limited Settings: Increased neurological dysfunction.

C. Marra, R. Price, U. Lalloo, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of second-line antiretroviral regimens on lipid profiles in an African setting: the DART trial sub-study

W. Tinago, C. Gilks, E. Katabira, 2014, AIDS Research and Therapy.

Cryptococcus myelitis: atypical presentation of a common infection.

J. Hakim, T. Gumbo, A. Ismail, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Neurocognitive Function at the First-Line Failure and on the Second-Line Antiretroviral Therapy in Africa: Analyses From the EARNEST Trial

A. Kambugu, J. V. van Oosterhout, N. Paton, 2016, Journal of acquired immune deficiency syndromes.

Sex-Associated Differences in Pre-Antiretroviral Therapy Plasma HIV-1 RNA in Diverse Areas of the World Vary by CD4+ T-Cell Count

T. Flanigan, J. Currier, L. Smeaton, 2011, Antiviral therapy.

Track C Epidemiology and Prevention Science

David R. Holtgrave, W. Heneine, Y. Nakamura, 2012, Journal of the International AIDS Society.

International neurocognitive normative study: neurocognitive comparison data in diverse resource-limited settings: AIDS Clinical Trials Group A5271

C. Marra, N. Sacktor, K. Robertson, 2016, Journal of Neurovirology.

A multinational study of neurological performance in antiretroviral therapy-naïve HIV-1-infected persons in diverse resource-constrained settings

C. Marra, R. Price, C. Hall, 2011, Journal of NeuroVirology.

Rapid emergence of resistance to penicillin and trimethoprim-sulphamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe.

R. Heyderman, J. Hakim, P. Mason, 2003, International journal of antimicrobial agents.

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe

C. Gilks, J. Darbyshire, J. Kigozi, 2012, PloS one.

Least among equals.

D. Kuritzkes, I. Sanne, J. Hakim, 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Empiric Tuberculosis Therapy versus Isoniazid in Advanced HIV-infected Adult Outpatients Initiating Antiretroviral Therapy : a Multi-Country Randomized Controlled Trial

V. Veloso, M. Hosseinipour, J. Kumwenda, 2016 .

Impact of routine laboratory monitoring over 5 years after antiretroviral therapy (ART)initiation on clinical disease progression of HIV-infected African adults: the DART Trial finalresults

C. Gilks, J. Darbyshire, E. Katabira, 2009 .

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda

D. Pillay, J. Kigozi, E. Katabira, 2014, The Journal of antimicrobial chemotherapy.

HIV treatment and care systems: the way forward

I. Weller, J. Hakim, A. South, 2012, AIDS.

Cost Effectiveness Analysis of Routine Laboratory or Clinically Driven Strategies for Monitoring Anti-Retroviral Therapy in Uganda and Zimbabwe (DART Trial)

C. Gilks, J. Darbyshire, J. Kigozi, 2009 .

Evidence for Action on HIV treatment and care systems in low and middle-income countries: background and introduction

I. Weller, J. Hakim, A. South, 2012, AIDS.

Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

M. Reitsma, J. Mellors, R. Kantor, 2015, Clinical Infectious Diseases.

Estimating Glomerular Filtration Rate in HIV-Infected Adults in Africa: Comparison of Cockcroft–Gault and Modification of Diet in Renal Disease Formulae

C. Gilks, J. Darbyshire, W. Stöhr, 2008, Antiviral therapy.

One Month of Rifapentine plus Isoniazid to Prevent HIV‐Related Tuberculosis

R. Chaisson, S. Swindells, C. Fletcher, 2019, The New England journal of medicine.

Patient Retention, Clinical Outcomes and Attrition-Associated Factors of HIV-Infected Patients Enrolled in Zimbabwe's National Antiretroviral Therapy Programme, 2007–2010

A. Abdul-Quader, L. Lynen, S. Rusakaniko, 2014, bioRxiv.

Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial

A. Zolopa, V. Veloso, M. Hosseinipour, 2016, The Lancet.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial

A. Breckenridge, P. Kaleebu, D. Pillay, 2010, The Lancet.

Inflammation and Change in Body Weight With Antiretroviral Therapy Initiation in a Multinational Cohort of HIV-Infected Adults.

R. Bollinger, D. Asmuth, L. Smeaton, 2016, The Journal of infectious diseases.

Assessment of second-line antiretroviral regimens for HIV therapy in Africa.

P. Easterbrook, A. Siika, A. Kambugu, 2014, The New England journal of medicine.

NeuroAIDS in Africa

C. Adebamowo, I. Grant, D. Clifford, 2010, Journal of NeuroVirology.

Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial

J. Seeley, N. Klein, F. Fitzgerald, 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Impact of sub-optimal HIV viral control on activated T cells

C. Kityo, N. Paton, J. Hakim, 2023, AIDS.